Image

Integrated Supportive and Palliative Care for Older Adults in the ICU

Recruiting
60 years of age
Both
Phase N/A

Powered by AI

Overview

The National Academy of Medicine and the National Institutes of Health have called for urgent action to improve the care delivered to the nearly 1,000,000 older Americans who die in intensive care units (ICUs) annually, or survive with substantial impairments. These patients often die with distressing symptoms and may receive more invasive, life-prolonging treatment than they would choose for themselves. Moreover, their family members acting as surrogate decision makers often experience lasting psychological distress from the ICU experience. The investigators will conduct a randomized trial among 500 patients and 750 surrogates and up to 1250 clinicians to determine whether early integration of specialty palliative care with standard critical care can improve outcomes for critically ill older patients at high risk of death or severe functional impairments and their family members.

Eligibility

Patient Inclusion Criteria

  1. Admitted to a participating study ICU
  2. Age greater than or equal to 60 years
  3. Meets one or more of the following acute or chronic triggers for PC consultation
    Acute
    • Cardiac or respiratory arrest with coma
    • Ischemic or hemorrhagic stroke requiring mechanical ventilation
    • ICU admission after hospital stay of greater than or equal to 10 days or ICU readmission within 30 days
    • Age greater than or equal to 80 and 1 or more forms of organ support
    • Multiorgan system failure
    • CCM physician judgment of greater than or equal to 50% risk of in-hospital death or new severe long term functional impairment
    Chronic
    • Admission from a SNF or LTACH with progressive functional decline
    • Metastatic (stage IV) cancer or advanced cancer without curative treatment
    • End stage cardiorespiratory disease
    • End stage liver disease
    • Advanced dementia or other end-stage neurologic disease
    • Age greater than or equal to 80 with two or more major comorbidities
    • Moderate-severe frailty (excluding stable intellectual or physical disability
      1. Pittsburgh Cardiac Arrest Category (PCAC) greater than or equal to 2
      2. Organ support: RRT, invasive or non-invasive mechanical ventilation, vasopressors
      3. Sequential Organ Failure Assessment (SOFA) score greater than or equal to 10
      4. Model for End-Stage Liver Disease (MELD) greater than or equal to 30
      5. Major comorbidities defined by Charlson Co-morbidity Index (CCI)
      6. Clinical Frailty Scale (CFS) score greater than or equal to 6

Patient Exclusion

  • No surrogate decision maker
  • Already received (or refused) a Palliative Care consultation during the same hospitalization
  • Determined to be imminently dying (within hours) by CCM physician
  • Within 1 year of receiving organ transplant, or actively undergoing work-up for organ transplant
  • Non-English speaking

Surrogate Inclusion

  • Primary surrogate, as determined by the patient's advance directive or by the hierarchy codified in state law
  • Up to 3 additional surrogates

Surrogate Exclusion

  • Age <18
  • Cannot read or understand English
  • Cannot complete surveys due to physical or cognitive limitations

Clinician Inclusion

•Patient's primary attending (or their designee)

Study details

Critical Illness

NCT04921631

University of Pittsburgh

7 June 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.